Abstract
IntroductionThe PANTS study highlights that secondary loss of response to anti-TNF treatment can be related to low drug levels1 caused by development of anti-drug antibodies (ADA).2 Early therapeutic drug monitoring...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
